AA
BLUE

Apriem Advisors’s bluebird bio BLUE Stock Holding History

Apriem Advisors’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-39
Closed -$60K – 630
2015
Q1 		$60K Buy
+39
New +$51.5K 0.02% 191

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Apriem Advisors's BLUE Position: Q2 2015 in Review

Apriem Advisors sold out of bluebird bio (BLUE) in Q2 2015, closing a stake of 39 shares — an estimated $60K sold.

Apriem Advisors first reported a position in BLUE in Q1 2015 and held it in 1 quarter. The position peaked at $60K in Q1 2015. 235 funds tracked by Wall St. Rank hold BLUE as of Q2 2015.

  • Apriem Advisors reported no remaining bluebird bio position as of Q2 2015 after selling out during the quarter.
  • Apriem Advisors sold 39 bluebird bio shares in Q2 2015, an estimated $60K.
  • Apriem Advisors first reported a position in bluebird bio in Q1 2015 and held it in 1 quarter.
  • Apriem Advisors's bluebird bio position peaked at $60K in Q1 2015.
  • 235 funds tracked by Wall St. Rank held bluebird bio as of Q2 2015.

Based on Apriem Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.